BioSpace News Archive

Based on an entirely new mechanism of action, ISB 830 has the potential to treat a range of autoimmune diseases beyond atopic dermatitis

Wisdom Health - the world’s leader in pet genetics and researchers at Purdue University announced the most comprehensive study of dog coat color and physical trait genes ever conducted is published in PLOS ONE.

As Adamis has previously stated, in connection with its acceptance for review of the NDA the FDA previously provided a PDUFA target agency action date of October 31, 2019.

Simcere will be responsible for the clinical development and commercialization of AER-271 in Greater China.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder law firm, has launched an investigation into whether the board members of Wright Medical Group N.V. breached their fiduciary duties or violated the federal securities laws in connection with the company’s proposed sale to Stryker Corporation..

Seattle Genetics, Inc. released the following statement in response to Daiichi Sankyo’s filing of a Declaratory Judgment action alleging Seattle Genetics is not entitled to intellectual property rights under a collaboration between the two companies for the development of antibody-drug conjugates

It was the first randomized, controlled trial comparing Toujeo to Gla-100 in this patient population.

Late Friday, President Donald Trump put forth Hahn’s name to take over the top spot of the nation’s regulatory agency.

Researchers at Rensselaer Polytechnic Institute developed a technique for 3D printing living skin that also has blood vessels.

Halozyme Therapeutics will halt development of a metastatic pancreatic cancer drug after it failed to demonstrate an improvement in overall survival in a Phase III trial.